Klöckner Pentaplast’s Pharmaceutical & Medical Device Films Division, known as kp Pharma, has completed the expansion of its Suzhou China facility, which included the installation of a ‘state-of-the-art’ slitting line that is expected to reduce lead times and increase flexibility for all material grades supplied into the Chinese market through local storage and supply. The new qualified slitting centre in China has achieved ISO 15378…